vorinostat has been researched along with DDPAC in 3 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alquezar, C | 1 |
| Esteras, N | 1 |
| de la Encarnación, A | 1 |
| Moreno, F | 1 |
| López de Munain, A | 1 |
| Martín-Requero, Á | 1 |
| Almeida, S | 2 |
| Gao, F | 1 |
| Coppola, G | 2 |
| Gao, FB | 2 |
| Cenik, B | 1 |
| Sephton, CF | 1 |
| Dewey, CM | 1 |
| Xian, X | 1 |
| Wei, S | 1 |
| Yu, K | 1 |
| Niu, W | 1 |
| Coughlin, SE | 1 |
| Lee, SE | 1 |
| Dries, DR | 1 |
| Geschwind, DH | 1 |
| Miller, BL | 1 |
| Farese, RV | 1 |
| Posner, BA | 1 |
| Yu, G | 1 |
| Herz, J | 1 |
3 other studies available for vorinostat and DDPAC
| Article | Year |
|---|---|
Increasing progranulin levels and blockade of the ERK1/2 pathway: upstream and downstream strategies for the treatment of progranulin deficient frontotemporal dementia.
Topics: Aged; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Chloroquine; DNA-Binding Pr | 2015 |
Suberoylanilide hydroxamic acid increases progranulin production in iPSC-derived cortical neurons of frontotemporal dementia patients.
Topics: Cell Differentiation; Cell Survival; Cells, Cultured; Cerebral Cortex; Frontotemporal Dementia; Gene | 2016 |
Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia.
Topics: Dose-Response Relationship, Drug; Frontotemporal Dementia; HEK293 Cells; Histone Deacetylase Inhibit | 2011 |